Stockreport
Prezent Taps Janet Dorling to Join Board and Fuel the Next Wave of AI Innovation in Biopharma [Yahoo! Finance]
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
LOS ALTOS, Calif. April 10, 2025 /PRNewswire/ -- Prezent, the enterprise-grade AI platform for business presentations, today announced the strategic appointment of Janet Dorling to its Board of Directors. As Senior Vice President at Gilead Sciences, a global biopharmaceutical company focused on advancing innovative treatments for serious diseases, Dorling brings 25+ years of leadership experience across both startups and large-scale enterprises. Her global purview and deep expertise in the complex biotech and pharma landscape will be invaluable as Prezent continues its mission to solve one of the most costly problems in business today: ineffective communication. Dorling has led global teams covering more than 150 countries and currently serves on the Advisory Board for the Robinson Life Science, Business, and Entrepreneurship Program at the University of California, Berkeley . She holds a BS in Molecular and Cellular Biology and a Master's in Pharmacology and Cancer Biology and a
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans [Yahoo! Finance][Yahoo! Finance]
- Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans[Business Wire]
- Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance [Yahoo! Finance][Yahoo! Finance]
- Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance[Business Wire]
- Gilead's Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial [Yahoo! Finance][Yahoo! Finance]
- More
GILD
SEC Filings
SEC Filings
- 12/16/25 - Form 4
- 12/16/25 - Form 4
- 12/15/25 - Form 144
- GILD's page on the SEC website
- More